We are live on ! Find out more
AA

ABC Arbitrage Portfolio holdings

AUM $926M
1-Year Est. Return 45.9%
This Fund
S&P 500
This Quarter Est. Return
+9.79%
1 Year Est. Return
+45.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$876M
AUM Growth
+$337M
Cap. Flow
+$284M
Cap. Flow %
32.48%
Top 10 Hldgs %
33.79%
Holding
286
New
95
Increased
68
Reduced
35
Closed
88

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$23.5M
2
SNN icon
Smith & Nephew
SNN
+$23.2M
3
RELX icon
RELX
RELX
+$19.4M
4
BTI icon
British American Tobacco
BTI
+$17.9M
5
ERIC icon
Ericsson
ERIC
+$16.5M

Top Sells

Rank Stock Value
1
GFI icon
Gold Fields
GFI
+$12.8M
2
UL icon
Unilever
UL
+$9.06M
3
AMX icon
America Movil
AMX
+$8.86M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$8.28M
5
NGG icon
National Grid
NGG
+$6.39M

Sector Composition

Rank Sector Weight
1 Healthcare 15.47%
2 Financials 14.09%
3 Technology 11.65%
4 Consumer Staples 11.48%
5 Materials 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCL icon
126
Carnival Corporation Ltd
CCL
$31.2B
$1.49M 0.17%
+52,816
New +$1.13M
CRM icon
127
Salesforce
CRM
$204B
$1.48M 0.17%
5,429
-424
-7% -$113K
NOW icon
128
ServiceNow
NOW
$137B
$1.48M 0.17%
7,175
-2,650
-27% -$500K
TEAM icon
129
Atlassian
TEAM
$45.5B
$1.46M 0.17%
+7,202
New +$1.5M
VIGL
130
DELISTED
Vigil Neuroscience
VIGL
$1.46M 0.17%
+183,179
New +$821K
ABBV icon
131
AbbVie
ABBV
$454B
$1.44M 0.16%
7,766
+131
+2% +$24.3K
EXE
132
Expand Energy Corp
EXE
$22B
$1.44M 0.16%
+12,290
New +$1.37M
VRTX icon
133
Vertex Pharmaceuticals
VRTX
$131B
$1.43M 0.16%
+3,221
New +$1.48M
KMB icon
134
Kimberly-Clark
KMB
$32.6B
$1.35M 0.15%
10,465
+1,840
+21% +$249K
EWU icon
135
iShares MSCI United Kingdom ETF
EWU
$3.76B
$1.29M 0.15%
32,419
+316
+1% +$12.1K
SBUX icon
136
Starbucks
SBUX
$113B
$1.24M 0.14%
13,564
+1,103
+9% +$95.6K
RDFN
137
DELISTED
Redfin
RDFN
$1.15M 0.13%
103,054
-406,370
-80% -$3.99M
KWEB icon
138
KraneShares CSI China Internet ETF
KWEB
$4.75B
$1.15M 0.13%
33,557
+1,600
+5% +$53K
IVZ icon
139
Invesco
IVZ
$14.3B
$1.12M 0.13%
71,245
+37,400
+111% +$537K
PEP icon
140
PepsiCo
PEP
$186B
$1.12M 0.13%
8,492
+349
+4% +$47K
DE icon
141
Deere & Co
DE
$182B
$1.1M 0.13%
+2,170
New +$1.06M
ITW icon
142
Illinois Tool Works
ITW
$76.4B
$1.1M 0.13%
4,446
-747
-14% -$180K
NOC icon
143
Northrop Grumman
NOC
$73.7B
$1.1M 0.13%
+2,195
New +$1.08M
RTX icon
144
RTX Corp
RTX
$266B
$1.1M 0.13%
+7,510
New +$1M
LEN.B icon
145
Lennar Class B
LEN.B
$18.9B
$1.08M 0.12%
10,232
+2,304
+29% +$238K
E icon
146
ENI
E
$80.6B
$1.04M 0.12%
32,110
+14,151
+79% +$420K
AZO icon
147
AutoZone
AZO
$47B
$1.02M 0.12%
+275
New +$1.01M
NTES icon
148
NetEase
NTES
$74B
$995K 0.11%
+7,391
New +$850K
ICAD
149
DELISTED
iCAD Inc
ICAD
$986K 0.11%
+258,673
New +$863K
VLO icon
150
Valero Energy
VLO
$112B
$981K 0.11%
+7,298
New +$909K

Similar funds

ABC Arbitrage's Q2 2025 Portfolio in Review

As of Q2 2025, ABC Arbitrage held 286 positions worth $876M, up 63% from $538M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ABC Arbitrage deployed $284M of net new capital in Q2 2025, opening 95 new positions and adding to 68 existing holdings. Its largest new stake was Novartis: 208,708 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Unilever, an estimated $9.06M trimmed.

  • ABC Arbitrage's largest Q2 2025 buy was Novartis: 208,708 shares worth $25.3M.
  • ABC Arbitrage added most to Smith & Nephew in Q2 2025, an estimated $23.2M increase.
  • ABC Arbitrage's biggest Q2 2025 reduction was Unilever, cutting an estimated $9.06M.
  • ABC Arbitrage fully exited Gold Fields in Q2 2025, selling an estimated $12.8M.
  • ABC Arbitrage's ten largest holdings make up 34% of its $876M portfolio in Q2 2025.
  • ABC Arbitrage opened 95 new positions and closed 88 in Q2 2025.
  • ABC Arbitrage's portfolio value rose 63% quarter-over-quarter to $876M.

Based on ABC Arbitrage's 13F filing for Q2 2025, filed 8 Aug 2025.